blog.aids.gov − Historic HIV Vaccine Clinical Trial: Facebook Live with NIH’s Dr. Dieffenbach

blog.aids.gov − Historic HIV Vaccine Clinical Trial: Facebook Live with NIH’s Dr. Dieffenbach

HISTORIC HIV VACCINE CLINICAL TRIAL: FACEBOOK LIVE WITH NIH’S DR. DIEFFENBACH

December 2, 2016 • By AIDS.gov 

In a Facebook Live interview from Cape Town, South Africa earlier this week, we heard from NIH’s Dr. Carl Dieffenbach about the exciting launch of HVTN 702, a new HIV vaccine clinical trial supported by NIH. The first HIV vaccine efficacy study to launch anywhere in seven years, HVTN 702 is testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.

Read more about the HVTN 702 trial.

Related posts:

1. Watch HIV Vaccine Trial Launch in South Africa Via Facebook Live! This Wednesday!
2. First New HIV Vaccine Efficacy Study in Seven Years Has Begun
3. HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
4. HIV Vaccine Research: Update from NIH’s Dr. Dieffenbach from 2nd Day of AIDS 2016
5. Future Directions for NIAID’s HIV Vaccine Clinical Research